Skip to content

Ayurveda management of Pratishyaya in children

Clinical study to evaluate the effect of oral administration of Tulasi Arka on Pratishyaya (Rhinitis) in children

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/07/043629
Enrollment
30
Registered
2022-07-01
Start date
Unknown
Completion date
Unknown
Last updated
2022-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J069- Acute upper respiratory infection,unspecified Health Condition 2: J309- Allergic rhinitis, unspecified Health Condition 3: J308- Other allergic rhinitis

Interventions

Intervention1: Tulasi Arka: Orally administration. 2-4 years - 3ml, three times in a day for 7 days. 5-6 years - 5ml, three times in a day for 7 days. Control Intervention1: NIL: NIL

Sponsors

Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital Hassan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Children between the age group of 2-6 years. 2. Children with Pratishyaya of recent onset within one week. 3. Children irrespective of gender, religion and socio-economic status fulfilling the diagnostic criteria.

Exclusion criteria

Exclusion criteria: 1. Congenital anomalies related to respiratory system. 2. Lower respiratory tract infection. 3. Jwara( >100oF) 4. Dushtapratishyaya, Raktapratishyaya and Sannipatajapratishyaya. 5. Chronic rhinitis, Sinusitis, Asthma, Infectious diseases like T.B. and other systemic disorders which interfere during the course of treatment.

Design outcomes

Primary

MeasureTime frame
Reduction in symptoms of Pratishyaya like Nasasrava, Kshvathu, Ghranoparodha,Jwara, Kasa etcTimepoint: Tulasi Arka orally administrated for 7 days & Response of drug compound will be assessed on 0, 4th & 8th day. Follow up assessment will be done on 14th day.

Secondary

MeasureTime frame
Patient well being,symptoms of Pratishyaya are reduced.Timepoint: Tulasi Arka orally administrated for 7 days & Response of drug compound will be assessed on 0, 4th & 8th day. Follow up assessment will be done on 14th day.

Countries

India

Contacts

Public ContactDr Vijayalaxmi Mallannavar

Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital, Hassan

abtittu@gmail.com9480624829

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026